RLDatix announced Oct. 17 it entered into a definitive agreement to acquire Porzio Life Sciences, a software provider for the life sciences industry that has been a wholly owned subsidiary of Morristown-based law firm Porzio, Bromberg & Newman since 2004.
The Chicago-based health care tech company said it expects the deal – terms of which were not disclosed – to be finalized early next month, subject to customary closing conditions.
Combined with RLDatix’s governance, risk, compliance and workforce management offerings, the acquisition will broaden the company’s reach across the life sciences industry.
“We’re excited to bring these capabilities together and to forge an innovative new path forward for our hundreds of pharmaceutical, biotech and medical device clients around the world,” RLDatix CEO Jeff Surges said in a statement.
After the deal is finalized, Porzio, Bromberg & Newman will continue to maintain a relationship with the company and will work with RLDatix to co-market products and services, along with other collaborations.
Porzio Life Sciences founder John Oroho will be named president and general manager of RLDatix’s life sciences division.
“The success of Porzio Life Sciences was always predicated on the notion of being built from the law,” said Oroho, a lawyer with Porzio, Bromberg & Newman. “As we join forces with RLDatix, I am inspired by their commitment to putting the voice of the customer at the forefront of everything they do.”
Vito Gagliardi Jr., managing principal at Porzio, Bromberg & Newman, said it was “a great day for our clients.”
Gagliardi added, “Under RLDatix’s leadership, Porzio Life Sciences will continue to simplify the compliance efforts of pharmaceutical companies while benefiting from the global scale and reach that is critical to driving ongoing success and growth.”